Background: Low vagal tone (VT) is a marker of vulnerability to stress and the risk of developing necrotizing enterocolitis in preterm infants. Electric fields produced by equipment in the neonatal intensive care unit (NICU) induce an electric potential measurable on the skin in reference to ground. An electrical connection to ground reduces the skin potential and improves VT in adults. Objectives: We aimed to measure the electric field strengths in the NICU environment and to determine if connecting an infant to electrical ground would reduce the skin potential and improve VT. We also wished to determine if the skin potential correlated with VT. Methods: Environmental magnetic flux density (MFD) was measured in and around incubators. Electrical grounding (EG) was achieved with a patch electrode and wire that extended to a ground outlet. We measured the skin potential in 26 infants and heart rate variability in 20 infants before, during, and after grounding. VT was represented by the high-frequency power of heart rate variability. Results: The background MFD in the NICU was below 0.5 mG, but it ranged between 1.5 and 12.7 mG in the closed incubator. A 60-Hz oscillating potential was recorded on the skin of all infants. With EG, the skin voltage dropped by about 95%. Pre-grounding VT was inversely correlated with the skin potential. VT increased by 67% with EG. After grounding, the VT fell to the pre-grounding level. Conclusion: The electrical environment affects autonomic balance. EG improves VT and may improve resilience to stress and lower the risk of neonatal morbidity in preterm infants.

Keywords:
Electromagnetic fields, Vagal tone, Electrical grounding, Heart rate variability
1.
Bearer CF: Electromagnetic fields and infant incubators. Arch Environ Health 1994;49:352-354.
2.
Bullough J, Rea MS, Stevens RG: Light and magnetic fields in a neonatal intensive care unit. Bioelectromagnetics 1996;17:396-405.
3.
Cermáková E: Study of extremely low frequency electromagnetic fields in infant incubators. Int J Occup Med Environ Health 2003;16:215-220.
4.
Li DK, Chen H, Odouli R: Maternal exposure to magnetic fields during pregnancy in relation to the risk of asthma in offspring. Arch Pediatr Adolesc Med 2011;165:945-950.
5.
Li DK, Ferber JR, Odouli R, Quesenberry CP Jr: A prospective study of in-utero exposure to magnetic fields and the risk of childhood obesity. Sci Rep 2012;2:540.
6.
Johansson O: Disturbance of the immune system by electromagnetic fields - a potentially underlying cause for cellular damage and tissue repair reduction which could lead to disease and impairment. Pathophysiology 2009;16:157-177.
7.
Bellieni CV, Acampa M, Maffei M, Maffei S, Perrone S, Pinto I, Stacchini N, Buonocore G: Electromagnetic fields produced by incubators influence heart rate variability in newborns. Arch Dis Child Fetal Neonatal Ed 2008; 93:F298-F301.
8.
Porges SW: Vagal tone: a physiologic marker of stress vulnerability. Pediatrics 1992;90(pt 2): 498-504.
9.
Doheny KK, Palmer C, Browning KN, Jairath P, Liao D, He F, Travagli RA: Diminished vagal tone is a predictive biomarker of necrotizing enterocolitis-risk in preterm infants. Neurogastroenterol Motil 2014;26:832-840.
10.
Applewhite R: The effectiveness of a conductive patch and a conductive bed pad in reducing induced human body voltage via the application of earth ground. Eur Biol Bioelectromagnetics 2005;1:23-40.
11.
Ghaly M, Teplitz D: The biologic effects of grounding the human body during sleep as measured by cortisol levels and subjective reporting of sleep, pain, and stress. J Altern Complement Med 2004;10:767-776.
12.
Chevalier G, Sinatra ST: Emotional stress, heart rate variability, grounding and improved autonomic tone: clinical applications. Integr Med 2011;10:16-21.
13.
Rosen H, Craelius W, Curcie D, Hiatt M, Hegyi T: Spectral analysis of heart variability in the newborn infant. Biol Neonate 2000;77:224-229.
14.
American Heart Association (AHA) Task Force of the European Society of Cardiology the North American Society of Pacing Electrophysiology: Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Circulation 1996;93:1043-1065.
15.
Tracey KJ: Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest 2007;117:289-296.
16.
Strunk T, Inder T, Wang X, Burgner D, Mallard C, Levy O: Infection-induced inflammation and cerebral injury in preterm infants. Lancet Infect Dis 2014;14:751-762.
17.
Riminesi C, Andreuccetti D, Fossi R, Pezzati M: ELF magnetic field exposure in a neonatal intensive care unit. Bioelectromagnetics 2004;25:481-491.
18.
Ahlbom IC, Cardis E, Green A, Linet M, Savitz D, Swerdlow A; ICNIRP (International Commission for Non-Ionizing Radiation Protection) Standing Committee on Epidemiology: Review of the epidemiologic literature on EMF and health. Environ Health Perspect 2001;109(suppl 6):911-933.
19.
Lai H, Singh NP: Magnetic-field-induced DNA strand breaks in brain cells of the rat. Environ Health Perspect 2004;112:687-694.
20.
Chevalier G, Sinatra ST, Oschman JL, Sokal K, Sokal P: Earthing: health implications of reconnecting the human body to the Earth's surface electrons. J Environ Public Health 2012;2012:291541.
21.
Anisimov SV, Mareev EA, Bakastov SS: On the generation and evolution of aeroelectric structures in the surface layer. J Geophys Res Atmos 1999;104:14359-14367.
22.
Oschman JL: Can electrons act as antioxidants? A review and commentary. J Altern Complement Med 2007;13:955-967.
23.
Oschman JL, Chevalier G, Brown R: The effects of grounding (earthing) on inflammation, the immune response, wound healing, and prevention and treatment of chronic inflammatory and autoimmune diseases. J Inflamm Res 2015;8:83-96.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.